Background Inflammatory bowel disease is a global disease in the 21st century. We aimed
to assess the changing incidence and prevalence of inflammatory bowel disease around the …

Background & Aims The epidemiology of Helicobacter pylori infection has changed with
improvements in sanitation and methods of eradication. We performed a systematic review and …

Over 1 million residents in the USA and 2.5 million in Europe are estimated to have IBD,
with substantial costs for health care. These estimates do not factor in the 'real' price of IBD, …

Objective We sought to evaluate COVID-19 clinical course in patients with IBD treated with
different medication classes and combinations. Design Surveillance Epidemiology of …

BACKGROUND & AIMS: We conducted a systematic review to determine changes in the
worldwide incidence and prevalence of ulcerative colitis (UC) and Crohn's disease (CD) in …

The inflammatory bowel diseases (IBDs) are contemporary conditions of industrialized
societies. The prevalence of IBD continues to increase steadily in Western countries, and newly …

Background Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease
worldwide and the leading cause of liver-related morbidity and mortality. We aimed to predict …

Inflammatory bowel disease (IBD) is a global disease; its evolution can be stratified into four
epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence …

Background and Aims The impact of Coronavirus disease 2019 (COVID-19) on patients with
inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course …

Background & Aims The inflammatory bowel diseases (IBDs) are chronic diseases that often
require surgery. However, the risk of requirement of surgery over time has not been well …